DYA Group’s Initiative

In 2003, Dirgantara Yudha Artha (DYA) Group expanded its business into the healthcare equipment industry under PT Oneject Indonesia.

Auto Disable Syringe (ADS) and Safety Box Procurement

Establishing long-term partnerships with the Ministry of Health, Health Offices, and Community Health Centers for Auto Disable Syringe (ADS – 0.05 ml, 0.5 ml, 5 ml) products and Safety Boxes.

Blood Screening Reagent Procurement

Distributing Blood Screening Reagents to our key customers and partners, Palang Merah Indonesia (PMI) and Blood Transfusion Units (UTD RS) throughout Indonesia.

Contraceptive Devices and Drugs (ALOKON) Procurement

Distributing Contraceptive Devices and Drugs (ALOKON) to the National Population and Family Planning Agency (BKKBN) as a form of support for the government program.

Apheresis Kit Procurement 

Distributing Apheresis Kits to our partners, Palang Merah Indonesia (PMI), government and private hospitals, stem cell clinics, and Blood Transfusion Units at hospitals (UTD RS).

Bussiness Transfer

In March 2017, PT Dirgantara Yudha Artha transferred its medical device distribution business to PT Itama Ranoraya.

Initial Public Offering (IPO)

PT Itama Ranoraya Tbk is listed as a public company (Tbk) on the Indonesia Stock Exchange with the stock code ‘IRRA’.

Expansion into the Pharmaceutical Sector

Venturing into the pharmaceutical sector by selling Avimac as its flagship product.

Bussiness Movement and Corporate Transformation

Venturing into the surgical sector and expanding the network through collaboration with 8 (eight) new partners, including factories and principals, within a period of 1 (one) year.

The company has also made a significant contribution to various national health activities, introducing “Hi-Tech Healthcare Solutions” products, and undergoing transformation while changing the company logo.

Business Expansion

Distributing radiotherapy machines and HD, as well as venturing into the wholesale trade of fertilizers and agrochemical products, veterinary medical devices, radioactive substances, and ionizing radiation generators.

Expansion into the Critical Sector

Venturing into the critical care sector through new partnerships with partners from the United States.